LEADER 02803nam 2200637 a 450 001 9910822448003321 005 20230725053800.0 010 $a1-283-31757-5 010 $a9786613317575 010 $a1-935281-41-0 035 $a(CKB)2550000000064061 035 $a(EBL)795120 035 $a(OCoLC)762097621 035 $a(SSID)ssj0000536124 035 $a(PQKBManifestationID)12186279 035 $a(PQKBTitleCode)TC0000536124 035 $a(PQKBWorkID)10547088 035 $a(PQKB)11031832 035 $a(MiAaPQ)EBC795120 035 $a(Au-PeEL)EBL795120 035 $a(CaPaEBR)ebr10509675 035 $a(CaONFJC)MIL331757 035 $a(EXLCZ)992550000000064061 100 $a20110126d2011 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 10$aEffusion cytology$b[electronic resource] $ea practical guide to cancer diagnosis /$fParvin Ganjei-Azar, Merce? Jorda?, Awtar Krishan 210 $aNew York $cDemos Medical$dc2011 215 $a1 online resource (192 p.) 300 $aDescription based upon print version of record. 311 $a1-933864-65-6 320 $aIncludes bibliographical references and index. 327 $aBody-cavity fluid cytology -- General diagnostic criteria: benign versus malignant -- Types of malignancy based on conventional cytology and immunocytochemistry -- Major differential diagnoses -- Detection of the primary site of carcinomas -- Cerebrospinal fluid cytology -- Laboratory techniques -- Flow cytometry, immunoassays, and molecular techniques. 330 $aToday, cytology of body cavity fluids is an integral part of cancer staging. A positive diagnosis indicates a high-stage (III or IV) cancer in a majority of instances. General pathologists and cytotechnologists rely on routine cytomorphologic criteria to help oncologists in their staging of cancer patients. The diagnostic clarity, however, is challenged by many false negatives and occasional false positive results. The former is usually followed by an unnecessary surgical procedure in the case of an under-staged cancer and the latter may prevent treatment of a potentially curable disease due t 606 $aCytodiagnosis 606 $aCancer$xDiagnosis 606 $aBody fluids 606 $aCytology$xTechnique 615 0$aCytodiagnosis. 615 0$aCancer$xDiagnosis. 615 0$aBody fluids. 615 0$aCytology$xTechnique. 676 $a616.07/582 700 $aGanjei-Azar$b Parvin$01680829 701 $aJorda?$b Merce?$01680830 701 $aKrishan$b Awtar$01679515 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910822448003321 996 $aEffusion cytology$94049816 997 $aUNINA